msg news
The pharmaceutical industry holds high expectations for the potential of AI technologies. However, companies are facing challenges due to stringent regulatory demands that hinder smooth implementation. In the interview, Dr. Hans Klöcker, manager at msg industry advisors, sheds light
Artificial intelligence
A comparison of classic algorithms and artificial intelligence for error detection in V2X data shows: The improved results of AI come at a high price.
Consider the scenario of a panel discussion or a question-and-answer session featuring a group of experts in the relevant field. While these participants possess significant knowledge, they may also exhibit a degree of bias due to their established perspectives. Introducing an artificial intelligence (AI) as one of the participants could provide a refreshing dynamic.
msg survey
To what extent is generative AI already being used in large German companies? What are the main use cases? msg conducted an online survey together with the market research institute INNOFACT - with exciting results.
Interview
GenAI is transforming pharma. Dr. Dennis Janning reveals how to identify impactful, process-driven use cases while keeping compliance and human oversight at the core.
Reference
Explore how MSG uses reinforcement learning on systems of record to optimize operations. Discover innovative AI solutions for your business today!
Reference
Optimize lens quality with our AI-driven imperfection recognition solutions, ensuring high precision and reducing defect rates in production.
Reference
Erdwärme Grünwald supplies thousands of households in the Munich community of Grünwald and Unterhaching with heating energy from a local geothermal source.